FDA MoCRA Cosmetics Registration Guide for Importers | Yinrui Logistics – Shenzhen Yinrui International Logistics Co., Ltd.

Bottom line: US cosmetics oversight has moved from “almost unregulated at entrance” to mandatory compliance. Under MoCRA (Modernization of Cosmetics Regulation Act of 2022), any facility that manufactures or processes cosmetics distributed in the US must register with FDA and renew every two years, and a responsible person must list each marketed product annually. As of June 30, 2026, FDA counts 16,398 active registered facilities and roughly 1.3M active product listings. Unregistered or unlisted products face detention at the border and domestic distribution is a prohibited act once a registration is suspended. This guide—prepared with inputs from logistics expertise at Yinrui International Logistics—lays out the rules for importers and overseas factories.

1. Who Must Comply (At-a-Glance)

Party	Register/List?	Key action
US brand owner	✅	Act as Responsible Person; list products annually
Overseas (e.g. China) factory selling into US	✅	FDA facility registration + designate a US Agent
US importer / distributor	✅	Responsible-person duties + verify supply-chain facility registration
Beauty salons / non-manufacturing retailers	⚪	Usually exempt; self-branded lines add duties
Small business with < $1M avg annual cosmetics sales (compliant categories only)	⚪	Exempt registration/GMP/simplified records, if criteria met
Eye-mucosa / injectable / internal-use / >24h appearance-altering products	🔴	Never exempt—full compliance regardless of size

⚠️ Exemptions are “all or nothing”: sell even one non-exempt product (sunscreen/SPF, eyeliner, eyebrow tints) and you lose every exemption—full registration, listing and GMP apply.

2. What MoCRA Is: The Shift From Voluntary to Mandatory

MoCRA is the most significant expansion of FDA authority over cosmetics since the FD&C Act of 1938. It replaced the largely hands-off pre-market regime with mandatory facility registration, product listing, Good Manufacturing Practices (GMP), a Responsible Person regime, serious adverse-event reporting, and mandatory recall authority. Framework: FD&C Act §606–§609 and 21 CFR Parts 700/701/710.

Signed December 29, 2022, registration and listing began rolling out through 2023 with full FDA enforcement from mid-2024. US brands, overseas factories, and importers that have not yet registered/listed are now well past the initial window and at real border risk.

3. The Four Mandatory Obligations

### 3.1 Facility Registration (§607) — Renew Biennially – Who: every person operating a facility that manufactures/processes cosmetics distributed in the US must register; overseas facilities (Foreign Facilities) must also appoint a US Agent as FDA point of contact. – Cadence: registration renews every two years from the initial registration date (Biennial Renewal). FDA updated Cosmetics Direct on February 11, 2026 to show each registration’s status and renewal date with automated email reminders. Example: registered 2024-02-20 → renew by 2026-02-20. If you registered in the 2024 surge, your first renewals are due now. – Consequence: once a facility’s registration is suspended, distributing/selling that facility’s cosmetics in the US is a prohibited act; unregistered facilities face import detention.

### 3.2 Product Listing (§607c) — Annual Updates – A Responsible Person must list each marketed product, including ingredient statements (with appropriate fragrance/flavor summaries when applicable) and Responsible-Person info. – Timing: annually, plus promptly after significant ingredient/formulation changes.

### 3.3 Responsible Person & Safety Substantiation – The Responsible Person = the manufacturer, packer, or distributor whose name appears on the label under §609(a)/FPLA §4(a). They own safety records, listing, and adverse-event duties. – They must keep records substantiating product safety—animal testing is not required; scientifically robust existing data can support.

### 3.4 Serious Adverse-Event Reporting – A Responsible Person who receives a serious adverse event (death, life-threatening, hospitalization, disability, congenital anomaly, significant disfigurement, etc.) must report to FDA within 15 business days, including a copy of the label; material new info learned within one year must be reported within 15 business days as well.

4. Four Categories That Are NEVER Exempt

Even a qualifying small business must fully register/list if it touches any of these:

Never-exempt category	Typical products	Why
Regular contact with eye mucous membrane	Mascara, eyeliner, lash adhesive	high infection risk to the eye
Injectable cosmetics	Fillers, cosmetic injections	bypasses skin, enters body
Intended for internal use	Drinkable beauty shots / ingestible beauty products	systemic risk
Alters appearance >24h where removal isn’t part of normal use	Brow/eyelash dye, acrylic/gel nails	chemically long-lasting effect

Sunscreen/SPF cosmetics or anything with therapeutic claims (acne, whitening) typically fall under OTC drug / device rules—verify separately; they are not eligible for cosmetic small-business exemptions.

5. Real Impact on Importers & Overseas Suppliers

Border detention is a real risk: cosmetics now need compliant registration/listing data to clear smoothly; missing it can trigger refusal or upgraded entry processing.
Overseas factories are the overlooked weak link: many ODM/OEM plants serving the US market are unregistered. Brands that fail to verify their factory’s FDA registration risk a whole container being held when the chain is questioned.
White-label sellers aren’t bystanders: by putting their name on the label they often become the Responsible Person, taking on listing + adverse-event duties directly.
Small businesses misread the “exempt” label: eligibility hinges on categories sold; a single eye-area or SPF SKU removes the exemption.

6. Export Compliance Checklist (Actionable)

① Classify the product: is it a “cosmetic,” or does a claim push it into OTC drug/device? ② Confirm party & exemption: own production or OEM? Does the facility pass the $1M average sales threshold? Any never-exempt SKU in the line? ③ Overseas factories: complete FDA facility registration and lock in a US Agent (via a US-based compliance service if needed). ④ Responsible Person: list every marketed product (with ingredients) each year via Cosmetics Direct / ESG NextGen / SPL software; keep registration details current so renewals don’t lapse. ⑤ Establish safety-substantiation files and a 15-business-day serious-adverse-event reporting process. ⑥ Before shipping, hand your freight forwarder the FDA registration/listing acknowledgements and US Agent details alongside customs docs to reduce detention and exam risk.

7. FAQ

Does every cosmetic exported to the US need FDA registration?

In short, yes. Facilities that manufacture or process cosmetics distributed in the US must register and renew every two years, and a Responsible Person must list each marketed product annually. Some small businesses under about $1 million average annual cosmetics sales and not touching high-risk categories may qualify for exemptions, but selling even one never-exempt item (sun-care, eye-area, or appearance-altering beyond 24 hours) removes all of them.

How is MoCRA different from the old voluntary VCRP program?

VCRP was voluntary and was closed in March 2023. MoCRA made facility registration and product listing mandatory: unregistered/unlisted cosmetics may not be introduced into US interstate commerce. It is the start of true pre- and post-market FDA oversight of cosmetics.

Do Chinese factories or OEM plants need to register and get a US agent?

Yes. A foreign facility whose products are distributed in the US must complete FDA facility registration and designate a US Agent as FDA’s point of contact and for official correspondence. Operating without one undermines registration compliance and can hamper customs clearance.

At what revenue level does the small-business exemption still apply?

Average annual cosmetics sales under $1 million over the prior three years, adjusted for inflation. Exceed it at any point and you lose the exemption. Even below that, the exemption never covers eye-mucosa, injectable, internal-use, or longer-than-24-hour appearance-altering products regardless of revenue.

Can my shipment actually be detained if I haven't registered or listed?

Yes, there is real risk. FDA/CBP may detain shipments, ask you to supply registration/listing records, upgrade the entry, or refuse products from a facility whose registration has been suspended. Verify your supply chain’s facility registration and carry your acknowledgements before shipping.

8. Related Reading (Internal Links)

[CPSC eFiling Guide for Cross-Border Sellers](/en/cpsc-efiling-2026-ultimate-guide-cross-border-seller-compliance-filing/)
[Cross-Border Product Certification: FCC/FDA/UL/CPSC at a Glance](/en/cross-border-product-certification-guide-fcc-fda-ul-cpsc-at-a-glance/)
[US-China Tariff Stacking: Seven-Layer System](/en/us-china-tariff-stacking-panorama-2026-seven-layer-system-explained-ddp-composite-tax-formula/)

This guide reflects FDA rules as of the writing date and is for general compliance awareness. For US cosmetics logistics, FDA registration support, or US Agent setup, contact Yinrui International Logistics — YinruiLogistics.com · +86 181 0290 2805.

FDA MoCRA Cosmetics Registration Guide for Importers | Yinrui Logistics